fluoroquinolones
Showing 1 - 25 of 198
Urinary Tract Infections Trial in Winston-Salem (Antibiotic, Next Gen)
Recruiting
- Urinary Tract Infections
- Antibiotic
- Next Gen
-
Winston-Salem, North CarolinaWake Forest Health Sciences
May 26, 2022
Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation
Recruiting
- Tuberculosis, Multidrug-Resistant
-
Nairobi, Kenya
- +2 more
Mar 16, 2022
Ocular Flora Resistance From Repeated Topical Antibiotic Use
Completed
- Increased Drug Resistance
- Infection Resistant to Quinolones and Fluoroquinolones
-
Toronto, Ontario, CanadaSunnybrook Health and Sciences Centre
Mar 16, 2021
Keratitis; Infectious Disease (Manifestation) Trial in Geneva (PACK-CXL, Cefazolin in combination with either tobramycin or
Completed
- Keratitis; Infectious Disease (Manifestation)
- PACK-CXL
- +4 more
-
Geneva, GE, SwitzerlandUniversity of Geneva
Oct 16, 2020
Acute Male Urinary Tract Infection Trial in Paris (Ceftriaxone, Ofloxacine, Placebo of ofloxacine)
Unknown status
- Acute Male Urinary Tract Infection
- Ceftriaxone
- +2 more
-
Paris, FranceSaint Louis hospital
Feb 7, 2020
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
TB-CAPT MTB/XDR Study
Recruiting
- Tuberculosis
- +2 more
- Xpert MTB/XDR
-
Cape Town, South Africa
- +1 more
May 17, 2021
Blood Glucose, Low, Hypoglycemia Trial in Peshawar (Moxifloxacin 400mg, Gemifloxacin 320 MG)
Completed
- Blood Glucose, Low
- Hypoglycemia
- Moxifloxacin 400mg
- Gemifloxacin 320 MG
-
Peshawar, Khyber Pukhtan Khawa, PakistanKhyber Medical University,Peshawar
Jun 3, 2021
Endophthalmitis Trial in Paris (Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from
Active, not recruiting
- Endophthalmitis
- Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from samples taken from treated patients
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Oct 31, 2022
Urinary Tract Infections Trial in Besançon (Fosfomycin Oral Suspension)
Unknown status
- Urinary Tract Infections
- Fosfomycin Oral Suspension
-
Besançon, FranceBOUILLER
Mar 8, 2019
COPD Exacerbation Acute Trial in H?i Phòng (Beta-Lactams, Fluoroquinolone)
Completed
- COPD Exacerbation Acute
-
Hải Phòng, VietnamHaiphong International Hospital
May 4, 2021
Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients
Unknown status
- Tuberculosis, Multidrug-Resistant
- Centralized Therapeutic Drug Monitoring
-
Brisbane, Australia
- +12 more
Oct 8, 2019
Infective Endocarditis Trial in France (Levofloxacin, Rifampicin, Conventional IV treatment of staphylococci IE following
Recruiting
- Infective Endocarditis
- Levofloxacin
- +2 more
-
Aix en Provence, France
- +53 more
May 18, 2021
Escherichia Coli Bacteremia, Klebsiella Bacteraemia, Enterobacter Bacteraemia Trial in Worldwide (Step down to oral
Recruiting
- Escherichia Coli Bacteremia
- +5 more
- Step down to oral antimicrobial therapy
- IV antimicrobial therapy
-
Manama, Bahrain
- +6 more
Mar 26, 2022
Urinary Tract Infections Trial in Youngstown (Gentamicin, Standard of Care)
Recruiting
- Urinary Tract Infections
- Gentamicin
- Standard of Care
-
Youngstown, OhioSt. Elizabeth Youngstown Hospital
Jan 18, 2023
Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection Trial (Pivmecillinam and amoxicillin/clavulanic acid,
Not yet recruiting
- Urinary Tract Infections
- +2 more
- Pivmecillinam and amoxicillin/clavulanic acid
- Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility
- (no location specified)
Nov 18, 2022
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Staphylococcus Aureus and Escherichia Coli From Humans, Chicken
Not yet recruiting
- Drug Resistance, Microbial
- (no location specified)
Dec 7, 2022
Miscarriage Trial in France (hysteroscopy, Aspiration)
Not yet recruiting
- Miscarriage
- hysteroscopy
- Aspiration
-
Bordeaux, France
- +3 more
Mar 30, 2023
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Urinary Tract Infections, Catheter-Related Infections Trial in Philadelphia (methenamine hippurate, Ciprofloxacin)
Completed
- Urinary Tract Infections
- Catheter-Related Infections
- methenamine hippurate
- Ciprofloxacin
-
Philadelphia, Pennsylvania
- +3 more
Feb 3, 2022
Pneumonia, Urinary Tract Infection, Antibiotic Stewardship Trial (ROAD Home Intervention)
Not yet recruiting
- Pneumonia
- +3 more
- ROAD Home Intervention
- (no location specified)
Oct 23, 2023
Chronic Pelvic Pain, Chronic Prostatitis Trial in Xi'an (Percutaneous electrical nerve stimulation treatment)
Recruiting
- Chronic Pelvic Pain
- Chronic Prostatitis
- Percutaneous electrical nerve stimulation treatment
-
Xi'an, Shaanxi, ChinaXijing Hospital, Fourth Military Medical University
Jul 14, 2021
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022